These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Oswald Avery and the pneumococcus. Kushner I; Samols D Pharos Alpha Omega Alpha Honor Med Soc; 2011; 74(2):14-8. PubMed ID: 21615066 [No Abstract] [Full Text] [Related]
23. Untreated pneumococcal bacteraemia of cryptic origin in the human adult with spontaneous recovery. Austrian R S Afr Med J; 1986 Oct; Suppl():46-9. PubMed ID: 3535120 [No Abstract] [Full Text] [Related]
24. Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines. Picazo JJ Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():4-6. PubMed ID: 19366362 [TBL] [Abstract][Full Text] [Related]
25. The continuing problem of pneumococcal infection. Davies AJ; Kumaratne DS J Antimicrob Chemother; 1988 Apr; 21(4):387-91. PubMed ID: 3288603 [No Abstract] [Full Text] [Related]
26. The Earliest Success of Penicillin. Fishman R Am J Ophthalmol; 2016 Mar; 163():204. PubMed ID: 27351039 [No Abstract] [Full Text] [Related]
27. New insights into pneumococcal disease. Feldman C; Anderson R Respirology; 2009 Mar; 14(2):167-79. PubMed ID: 19272081 [TBL] [Abstract][Full Text] [Related]
28. [Development of antibiotic resistance of Pneumococcus. A new way for prescribing antibiotics in pediatrics]. Cohen R; Reinert P; Geslin P Arch Fr Pediatr; 1992 Feb; 49(2):77-9. PubMed ID: 1580741 [No Abstract] [Full Text] [Related]
29. Host defense against the pneumococcus in T-lymphocyte-deficient, nude mice. Winkelstein JA; Swift AJ Infect Immun; 1975 Nov; 12(5):1222-3. PubMed ID: 334 [TBL] [Abstract][Full Text] [Related]
30. Identification of proteins in Streptococcus pneumoniae by reverse vaccinology and genetic diversity of these proteins in clinical isolates. Argondizzo AP; da Mota FF; Pestana CP; Reis JN; de Miranda AB; Galler R; Medeiros MA Appl Biochem Biotechnol; 2015 Feb; 175(4):2124-65. PubMed ID: 25448632 [TBL] [Abstract][Full Text] [Related]
31. [Contribution of pneumococcal serotyping and antibiotyping to the prevention and treatment of pneumococcal infections (1980-1982). Pneumococcal typing and vaccination (1980-1982)]. Rouhan D; Le Noc P Rev Epidemiol Sante Publique; 1984; 32(6):352-9. PubMed ID: 6531496 [TBL] [Abstract][Full Text] [Related]
32. [Pneumococcus danger]. de Montalembert M Pediatrie; 1992; 47(5):375-7. PubMed ID: 1331953 [No Abstract] [Full Text] [Related]
33. Streptococcus pneumoniae: elusive mechanisms of the body's defense systems. Bondi T; Canessa C; Lippi F; Iacopelli J; Nieddu F; Azzari C J Prev Med Hyg; 2012 Jun; 53(2):89-93. PubMed ID: 23240166 [TBL] [Abstract][Full Text] [Related]
34. Observations regarding historical accounts of pneumococcal diseases due to serotypes 1 and 3. Inverarity DJ; Diggle MA J R Coll Physicians Edinb; 2010 Dec; 40(4):354-61. PubMed ID: 21132147 [TBL] [Abstract][Full Text] [Related]
35. Pneumolysin as a vaccine and drug target in the prevention and treatment of invasive pneumococcal disease. Cockeran R; Anderson R; Feldman C Arch Immunol Ther Exp (Warsz); 2005; 53(3):189-98. PubMed ID: 15995579 [TBL] [Abstract][Full Text] [Related]
37. [An update of Streptococcus pneumoniae: from genomic to clinic]. Wintenberger C Med Mal Infect; 2010 Oct; 40(10):605-9. PubMed ID: 20934286 [No Abstract] [Full Text] [Related]
38. Capsular type and the pneumococcal human host-parasite relationship. Crook DW Clin Infect Dis; 2006 Feb; 42(4):460-2. PubMed ID: 16421788 [No Abstract] [Full Text] [Related]
39. The enduring pneumococcus: unfinished business and opportunities for the future. Austrian R Microb Drug Resist; 1997; 3(2):111-5. PubMed ID: 9185136 [No Abstract] [Full Text] [Related]